| Name | Title | Contact Details |
|---|
ProKidney, a pioneer in the treatment of chronic kidney disease (CKD) through innovations in cellular therapy, was founded in 2015 after a decade of research. ProKidney`s lead product candidate, REACT® (Renal Autologous Cell Therapy), is a first-of-its-kind, patented disease-modifying autologous cellular therapy with the potential to not only slow and stabilize the progression of CKD, but in some cases drive meaningful improvement in kidney function. REACT® has received Regenerative Medicine Advanced Therapy (RMAT) designation, as well as FDA and EMA guidance, supporting an immediate start to a global registrational program, which launched in the United States on schedule in January 2022. On January 18, 2022, ProKidney announced that it would become a publicly traded company via a business combination with Social Capital Suvretta Holdings Corp. III
DocuSys, Inc. is one of the leading providers in Healthcare, Pharmaceuticals, & Biotech. It is based in Atlanta, GA. To find more information about DocuSys, Inc., please visit www.docusys.net
Founded in 1986, eQHealth Solutions is a population health management and technology solutions company that touches millions of lives annually throughout the nation. Our high-tech and high-touch models include innovative technology solutions and care coordination services, and focus on outcomes and optimization of provider and payer networks. eQHealth serves a variety of entities including federal, state and commercial clients.
Get personalized guidance and chat with live health experts any day of the year to help manage or prevent diabetes, lose weight, and boost energy levels
Vision Mondiale is a Sainte-Adle, QC-based company in the Healthcare, Pharmaceuticals, & Biotech sector.